公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2016 | The emergence of T790M mutation in EGFR-mutant lung adenocarcinoma patients having a history of acquired resistance to EGFR-TKI: Focus on rebiopsy timing and long-term existence of T790M | Tseng J.-S.; KANG-YI SU ; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen H.-Y.; Tsai C.-R.; SUNG-LIANG YU ; Chang G.-C. | Oncotarget | 24 | 23 | |
2011 | Epidermal growth factor receptor mutation status in stage i lung adenocarcinoma with different image patterns | Hsu K.-H.; Chen K.-C. ; Yang T.-Y.; Yeh Y.-C.; Chou T.-Y.; Chen H.-Y.; Tsai C.-R.; Chen C.-Y.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Tsai Y.-H.; KUAN-YU CHEN ; Huang M.-S.; Su W.-C.; Chen Y.-M.; Hsiung C.A.; Chang G.-C.; Chen C.-J.; PAN-CHYR YANG | Journal of Thoracic Oncology | 47 | 42 | |
2015 | Estrogen receptor gene polymorphisms and lung adenocarcinoma risk in never-smoking women | KUAN-YU CHEN ; Hsiao C.-F.; Chang G.-C.; Tsai Y.-H.; Su W.-C.; Chen Y.-M.; Huang M.-S.; Tsai F.-Y.; Jiang S.-S.; Chang I.-S.; Chen C.-Y.; Hsiung C.A.; Chen C.-J.; PAN-CHYR YANG | Journal of Thoracic Oncology | 21 | 14 | |
2020 | Exercise experiences in patients with metastatic lung cancer: A qualitative approach | Chang P.-H.; Lin C.-R.; YUN-HSIANG LEE ; Liu Y.-L.; Chang G.-C.; Hoogland A.I.; YEUR-HUR LAI | PLoS ONE | 6 | 3 | |
2021 | Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations | Chang G.-C.; Lam D.C.-L.; Tsai C.-M.; Chen Y.-M.; JIN-YUAN SHIH ; Aggarwal S.; Wang S.; Kim S.-W.; Kim Y.-C.; Wahid I.; Li R.; Lim D.W.-T.; Sriuranpong V.; Chan R.T.-T.; Lorence R.M.; Carriere P.; Raabe C.; Cseh A.; Park K. | International Journal of Clinical Oncology | 2 | 2 | |
2018 | FAM198B is associated with prolonged survival and inhibits metastasis in lung adenocarcinoma via blockage of ERK-Mediated MMP-1 expression | Hsu C.-Y.; Chang G.-C.; Chen Y.-J.; Hsu Y.-C.; Hsiao Y.-J.; KANG-YI SU ; Chen H.-Y.; Lin C.-Y.; JIN-SHING CHEN ; Chen Y.-J.; Hong Q.-S.; Ku W.-H.; Wu C.-Y.; Ho B.-C.; Chiang C.-C.; PAN-CHYR YANG ; SUNG-LIANG YU | Clinical Cancer Research | 19 | 20 | |
2016 | Fanconi anemia genes in lung adenocarcinoma - A pathway-wide study on cancer susceptibility | Yang S.-Y.; Hsiung C.-N.; Li Y.-J.; Chang G.-C.; Tsai Y.-H.; KUAN-YU CHEN ; Huang M.-S.; Su W.-C.; Chen Y.-M.; Hsiung C.A.; PAN-CHYR YANG ; Chen C.-J.; Wu P.-E.; Yu J.-C.; Shen C.-Y.; Hsu H.-M. | Journal of Biomedical Science | 15 | 14 | |
2007 | A five-gene signature and clinical outcome in non-small-cell lung cancer | Chen H.-Y.; SUNG-LIANG YU ; Chen C.-H.; Chang G.-C.; Chen C.-Y.; ANG YUAN ; Cheng C.-L.; Wang C.-H.; Terng H.-J.; Kao S.-F.; Chan W.-K.; Li H.-N.; Liu C.-C.; Singh S.; WEI J. CHEN ; Chen J.J.W.; PAN-CHYR YANG | New England Journal of Medicine | 794 | 735 | |
2009 | A four-gene signature from NCI-60 cell line for survival prediction in non-small cell lung cancer | Hsu Y.-C.; Yuan S.-S.; Chen H.-Y.; SUNG-LIANG YU ; Liu C.-H.; Hsu P.-Y.; Wu G.; Lin C.-H.; Chang G.-C.; Li K.-C.; PAN-CHYR YANG | Clinical Cancer Research | 47 | 43 | |
2017 | Gene expression of MAGE-A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non–small cell lung cancer patients | SZU-HUA PAN ; KANG-YI SU ; Spiessens B.; Kusuma N.; Delahaye N.F.; Gruselle O.; Myo A.; de Creus A.; Louahed J.; Chang G.-C.; SUNG-LIANG YU ; PAN-CHYR YANG | Asia-Pacific Journal of Clinical Oncology | 13 | 14 | |
2017 | Genetic modifiers of progression-free survival in never-smoking lung adenocarcinoma patients treated with first-line tyrosine kinase inhibitors | Chang I.-S.; Jiang S.-S.; CHIH-HSIN YANG ; Su W.-C.; Chien L.-H.; Hsiao C.-F.; JIH-HSIANG LEE ; Chen C.-Y.; Chen C.-H.; Chang G.-C.; Wang Z.; Lo F.-Y.; KUAN-YU CHEN ; Wang W.-C.; Chen Y.-M.; Huang M.-S.; Tsai Y.-H.; Su Y.-C.; Hsieh W.-S.; Shih W.-C.; Shieh S.-H.; Yang T.-Y.; Lan Q.; Rothman N.; Chen C.-J.; Chanock S.J.; PAN-CHYR YANG ; Hsiung C.A. | American Journal of Respiratory and Critical Care Medicine | 17 | 17 | |
2012 | Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum | WEI-YU LIAO ; JIN-YUAN SHIH ; Chang G.-C.; Cheng Y.-K.; CHIH-HSIN YANG ; Chen Y.-M.; CHONG-JEN YU | Journal of Thoracic Oncology | 50 | 50 | |
2012 | Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia | Hosgood III H.D.; Wang W.-C.; Hong Y.-C.; Wang J.-C.; Chen K.; Chang I.-S.; Chen C.-J.; Lu D.; Yin Z.; Wu C.; Zheng W.; Qian B.; Park J.Y.; Kim Y.H.; Chatterjee N.; Chen Y.; Chang G.-C.; Hsiao C.-F.; Yeager M.; Tsai Y.-H.; Wei H.; Kim Y.T.; Wu W.; Zhao Z.; Chow W.-H.; Zhu X.; Lo Y.-L.; Sung S.W.; KUAN-YU CHEN ; Yuenger J.; Kim J.H.; Huang L.; Chen Y.-H.; Gao Y.-T.; Kim J.H.; Huang M.-S.; Jung T.H.; Caporaso N.; Zhao X.; Huan Z.; Yu D.; Kim C.H.; Su W.-C.; Shu X.-O.; Kim I.-S.; Bassig B.; Chen Y.-M.; Cha S.I.; Tan W.; Chen H.; Yang T.-Y.; Sung J.S.; Wang C.-L.; Li X.; Park K.H.; CHONG-JEN YU ; Ryu J.-S.; Xiang Y.; Hutchinson A.; Kim J.S.; Cai Q.; Landi M.T.; Lee K.-M.; Hung J.-Y.; Park J.-Y.; Tucker M.; Lin C.-C.; Ren Y.; Perng R.-P.; Chen C.-Y.; Jin L.; Chen K.-C.; Li Y.-J.; Chiu Y.-F.; Tsai F.-Y.; PAN-CHYR YANG ; Fraumeni Jr. J.F.; Seow A.; Lin D.; Zhou B.; Chanock S.; Hsiung C.A.; Rothman N.; Lan Q. | Human Genetics | 34 | 33 | |
2015 | Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never-smoking women in Asia: A report from the female lung cancer consortium in Asia | Machiela M.J.; Hsiung C.-A.; Shu X.-O.; Seow W.J.; Wang Z.; Matsuo K.; Hong Y.-C.; Seow A.; Wu C.; Hosgood H.D.; III, Chen K.; Wu J.; Lim W.-Y.; Chen K.-C.; Chow W.-H.; Ji B.-T.; Chan J.K.C.; Chu M.; Li Y.-J.; Yokota J.; Li J.; Wang J.-C.; Chen H.; Xiang Y.-B.; CHONG-JEN YU ; Kunitoh H.; Wu G.; Jin L.; Lo Y.-L.; Shiraishi K.; Chen Y.-H.; Lin H.-C.; Wen W.; Wu T.; Wong M.P.; Wu Y.-L.; PAN-CHYR YANG ; Zhou B.; Shin M.-H.; Fraumeni J.F.; Jr.; Zheng W.; Lin D.; Cawthon R.; Chanock S.J.; Rothman N.; Lan Q.; Chatterjee N.; Hu W.; Caporaso N.E.; Park J.Y.; Chen C.-J.; Kim Y.H.; Kim Y.T.; Landi M.T.; Shen H.; Lawrence C.; Burdett L.; Yeager M.; Chang I.-S.; Mitsudomi T.; Kim H.N.; Chang G.-C.; Bassig B.A.; Tucker M.; Wei F.; Yin Z.; An S.-J.; Qian B.; Lee V.H.F.; Lu D.; Liu J.; Jeon H.-S.; Hsiao C.-F.; Sung J.S.; Kim J.H.; Gao Y.-T.; Tsai Y.-H.; Jung Y.J.; Guo H.; Hu Z.; Hutchinson A.; Wang W.-C.; Klein R.J.; Chung C.C.; Oh I.-J.; KUAN-YU CHEN ; Berndt S.I.; Wu W.; Chang J.; Zhang X.-C.; Huang M.-S.; Zheng H.; Wang J.; Zhao X.; Li Y.; Choi J.E.; Su W.-C.; Park K.H.; Sung S.W.; Chen Y.-M.; Liu L.; Kang C.H.; Hu L.; Chen C.-H.; Pao W.; Kim Y.-C.; Yang T.-Y.; Xu J.; Guan P.; Tan W.; Su J.; Wang C.-L.; Li H.; Sihoe A.D.L.; Zhao Z.; Chen Y.; Choi Y.Y.; Hung J.-Y.; Kim J.S.; Yoon H.-I.; Cai Q.; Lin C.-C.; Park I.K.; Xu P.; Dong J.; Kim C.; He Q.; Perng R.-P.; Kohno T.; Kweon S.-S.; Chen C.-Y.; Vermeulen R.C.H. | International Journal of Cancer | 79 | 67 | |
2012 | Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia | Lan Q.; Hsiung C.-A.; Matsuo K.; Hong Y.-C.; Seow A.; Wang Z.; Hosgood H.D.; Chen K.; Wang J.-C.; Chatterjee N.; Hu W.; Chen C.-Y.; Vermeulen R.; Wu J.; Lim W.-Y.; Chen K.-C.; Chow W.-H.; Ji B.-T.; Chan J.K.C.; Chu M.; Li Y.-J.; Wong M.P.; Yokota J.; Li J.; Chen H.; Xiang Y.-B.; CHONG-JEN YU ; Kunitoh H.; Wu G.; Jin L.; Lo Y.-L.; Shiraishi K.; Zheng W.; Chen Y.-H.; Lin H.-C.; Wu T.; Wu Y.-L.; PAN-CHYR YANG ; Zhou B.; Shin M.-H.; Fraumeni J.F.; Lin D.; Chanock S.J.; Caporaso N.; Rothman N.; Park J.Y.; Chen C.-J.; Kim Y.H.; Kim Y.T.; Landi M.T.; Shen H.; Lawrence C.; Burdett L.; Yeager M.; Yuenger J.; Jacobs K.B.; Chang I.-S.; Mitsudomi T.; Kim H.N.; Chang G.-C.; Bassig B.A.; Tucker M.; Wei F.; Yin Z.; Wu C.; An S.-J.; Qian B.; Lee V.H.F.; Lu D.; Liu J.; Jeon H.-S.; Hsiao C.-F.; Sung J.S.; Kim J.H.; Gao Y.-T.; Tsai Y.-H.; Jung Y.J.; Guo H.; Hu Z.; Hutchinson A.; Wang W.-C.; Klein R.; Chung C.C.; Oh I.-J.; KUAN-YU CHEN ; Berndt S.I.; He X.; Wu W.; Chang J.; Zhang X.-C.; Huang M.-S.; Zheng H.; Wang J.; Zhao X.; Li Y.; Choi J.E.; Su W.-C.; Park K.H.; Sung S.W.; Shu X.-O.; Chen Y.-M.; Liu L.; Kang C.H.; Hu L.; Chen C.-H.; Pao W.; Kim Y.-C.; Yang T.-Y.; Xu J.; Guan P.; Tan W.; Su J.; Wang C.-L.; Li H.; Sihoe A.D.L.; Zhao Z.; Chen Y.; Choi Y.Y.; Hung J.-Y.; Kim J.S.; Yoon H.-I.; Cai Q.; Lin C.-C.; Park I.K.; Xu P.; Dong J.; Kim C.; He Q.; Perng R.-P.; Kohno T.; Kweon S.-S. | Nature Genetics | 260 | 245 | |
2008 | High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy | Perng R.-P.; CHIH-HSIN YANG ; Chen Y.-M.; Chang G.-C.; Lin M.-C.; Hsieh R.-K.; Chu N.-M.; Lai R.-S.; Su W.-C.; Tsao C.-J.; Hsia T.-C.; Chen H.-C.; Chen C.-H.; Huang M.-S.; Wang J.-L.; Ho M.-L.; Chung C.-Y.; CHONG-JEN YU ; Chang W.-C.; Kuo H.-P.; Yu C.-T.; ZHONG-ZHE LIN ; Kao W.-Y. | Lung Cancer | 28 | 26 | |
2019 | High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment naïve advanced EGFR-mutant lung adenocarcinoma patients | Hsu K.-H.; Huang Y.-H.; Tseng J.-S.; Chen K.-C.; Ku W.-H.; KANG-YI SU ; Chen J.J.W.; HUEI-WEN CHEN ; SUNG-LIANG YU ; Yang T.-Y.; Chang G.-C. | Lung Cancer | 63 | 52 | |
2016 | Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients | Hsu K.-H.; Tseng J.-S.; Wang C.-L.; Yang T.-Y.; Tseng C.-H.; Chen H.-Y.; Chen K.-C.; Tsai C.-R.; Yang C.-T.; SUNG-LIANG YU ; KANG-YI SU ; CHONG-JEN YU ; CHAO-CHI HO ; Hsia T.-C.; Wu M.-F.; Chiu K.-L.; Liu C.-M.; PAN-CHYR YANG ; Chen J.J.W.; Chang G.-C. | Oncotarget | 9 | 9 | |
2010 | HLJ1 is a novel caspase-3 substrate and its expression enhances UV-induced apoptosis in non-small cell lung carcinoma | Lin S.-Y.; Hsueh C.-M.; SUNG-LIANG YU ; Su C.-C.; Shum W.-Y.; Yeh K.-C.; Chang G.-C.; Chen J.J.W. | Nucleic Acids Research | 27 | 25 | |
2016 | HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms | Chen C.-H.; Chang W.-H.; KANG-YI SU ; Ku W.-H.; Chang G.-C.; Hong Q.-S.; Hsiao Y.-J.; Chen H.-C.; Chen H.-Y.; Wu R.; PAN-CHYR YANG ; Chen J.J.W.; SUNG-LIANG YU | Oncogene | 21 | 21 |